{"id":566526,"date":"2026-09-12T02:00:00","date_gmt":"2026-09-12T00:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/piattaforme-di-sopravvivenza-con-botensilimab-balstilimab\/"},"modified":"2026-09-17T22:35:31","modified_gmt":"2026-09-17T20:35:31","slug":"piattaforme-di-sopravvivenza-con-botensilimab-balstilimab","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/it\/piattaforme-di-sopravvivenza-con-botensilimab-balstilimab\/","title":{"rendered":"Piattaforme di sopravvivenza con botensilimab + balstilimab"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>In occasione del congresso ESMO del 2025 sono stati presentati numerosi dati relativi ai tumori solidi. Tra questi figurava anche un&#8217;analisi aggiornata della combinazione di botensilimab e balstilimab.<\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fpiattaforme-di-sopravvivenza-con-botensilimab-balstilimab%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>In occasione del congresso ESMO del 2025 sono stati presentati numerosi dati relativi ai tumori solidi. Tra questi figurava anche un&#8217;analisi aggiornata della combinazione di botensilimab e balstilimab&#8230;. Dieser Inhalt&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fpiattaforme-di-sopravvivenza-con-botensilimab-balstilimab%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":566532,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Tumori solidi in stadio avanzato  ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11550,11376,11522,11515],"tags":[52568,101919,101917,18033,101937,101924,101929,22531,101927,24143,101923,101928,101925,101926,101931,44829,54739,101921,101936,101933,101922],"powerkit_post_featured":[],"class_list":["post-566526","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-it","category-oncologia-it","category-rapporti-del-congresso","category-studi","tag-anticorpo-ctla-4","tag-balstilimab","tag-botensilimab","tag-carcinoma-ovarico","tag-congresso-esmo-2025-2","tag-doppio-blocco-dei-checkpoint","tag-effetti-collaterali-di-natura-immunitaria-imae","tag-esmo-it","tag-hcc-refrattario-al-pd-l1","tag-inibitore-pd-1","tag-inibitori-dei-checkpoint-immunitari-ici","tag-metastasi-epatiche-attive","tag-mss-mcrc","tag-nsclc-refrattario-al-pd-1","tag-pazienti-che-non-hanno-mai-ricevuto-terapia-i-o","tag-sarcomi","tag-sopravvivenza-globale","tag-studio-c-800-01","tag-terapie-complementari","tag-tumori-refrattari-alla-terapia-i-o","tag-tumori-solidi-in-stadio-avanzato","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-25 00:17:03","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"it_IT","wpml_translations":{"pt_PT":{"locale":"pt_PT","id":566536,"slug":"plateaus-de-sobrevivencia-com-botensilimab-balstilimab","post_title":"Plateaus de sobreviv\u00eancia com botensilimab + balstilimab","href":"https:\/\/medizinonline.com\/pt-pt\/plateaus-de-sobrevivencia-com-botensilimab-balstilimab\/"},"es_ES":{"locale":"es_ES","id":566554,"slug":"mesetas-de-supervivencia-con-botensilimab-balstilimab","post_title":"Mesetas de supervivencia con botensilimab + balstilimab","href":"https:\/\/medizinonline.com\/es\/mesetas-de-supervivencia-con-botensilimab-balstilimab\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/566526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/comments?post=566526"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/566526\/revisions"}],"predecessor-version":[{"id":566642,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/566526\/revisions\/566642"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media\/566532"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media?parent=566526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/category?post=566526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/tags?post=566526"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/powerkit_post_featured?post=566526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}